LYTE THE WAY Trademark

Trademark Overview

On Tuesday, August 3, 2021, a trademark application was filed for LYTE THE WAY with the United States Patent and Trademark Office. The USPTO has given the LYTE THE WAY trademark a serial number of 90863901. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Friday, March 6, 2026. This trademark is owned by INTRA-CELLULAR THERAPIES, INC.. The LYTE THE WAY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations for the treatment of central nervous system diseases and disorders; Pharmaceutical preparations for the treatment of schizophrenia; Pharmaceutical preparations for the treatment of bipolar disorder
lyte the way

General Information

Serial Number90863901
Word MarkLYTE THE WAY
Filing DateTuesday, August 3, 2021
Status734 - FIFTH EXTENSION - GRANTED
Status DateFriday, March 6, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 18, 2023

Trademark Statements

Pseudo MarkLIGHT THE WAY
Goods and ServicesPharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations for the treatment of central nervous system diseases and disorders; Pharmaceutical preparations for the treatment of schizophrenia; Pharmaceutical preparations for the treatment of bipolar disorder

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, September 29, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameINTRA-CELLULAR THERAPIES, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBedminster, NJ 07921
US
Party NameINTRA-CELLULAR THERAPIES, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10016
US

Trademark Events

Event DateEvent Description
Friday, August 6, 2021NEW APPLICATION ENTERED
Wednesday, September 29, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, April 29, 2022ASSIGNED TO EXAMINER
Tuesday, May 3, 2022SUSPENSION LETTER WRITTEN
Tuesday, May 3, 2022LETTER OF SUSPENSION E-MAILED
Tuesday, May 3, 2022NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, July 29, 2022ASSIGNED TO EXAMINER
Wednesday, December 7, 2022REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, June 12, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 28, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 18, 2023PUBLISHED FOR OPPOSITION
Tuesday, July 18, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 12, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 12, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, March 12, 2024SOU EXTENSION 1 FILED
Tuesday, March 12, 2024SOU EXTENSION 1 GRANTED
Wednesday, March 13, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 13, 2024TEAS PETITION TO REVIVE RECEIVED
Friday, September 13, 2024PETITION TO REVIVE-GRANTED
Friday, September 13, 2024NOTICE OF REVIVAL - E-MAILED
Friday, September 13, 2024SOU EXTENSION RECEIVED WITH TEAS PETITION
Monday, December 9, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, September 12, 2024SOU EXTENSION 2 FILED
Tuesday, December 10, 2024SOU EXTENSION 2 GRANTED
Tuesday, December 10, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 10, 2025SOU TEAS EXTENSION RECEIVED
Tuesday, March 11, 2025SOU EXTENSION 3 FILED
Tuesday, March 11, 2025SOU EXTENSION 3 GRANTED
Tuesday, March 11, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 12, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, August 12, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, August 12, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, August 12, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, August 12, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, September 8, 2025SOU TEAS EXTENSION RECEIVED
Monday, September 8, 2025SOU EXTENSION 4 FILED
Monday, September 8, 2025SOU EXTENSION 4 GRANTED
Monday, September 15, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 23, 2026SOU TEAS EXTENSION RECEIVED
Sunday, February 22, 2026SOU EXTENSION 5 FILED
Friday, March 6, 2026SOU EXTENSION 5 GRANTED
Friday, March 6, 2026NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

lyte pharmaceutical preparations treatment nervous system central bipolar disorder schizophrenia disorders